SCI Pharmtech, Inc. (4119.TW) TAI
Currency In TWD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.82B |
| Enterprise Value | 6.75B |
| P/E Ratio | 53.33 |
| PEG Ratio | -0.65 |
| Price/Sales Ratio | 3.8 |
| Price/Book Ratio | 0.95 |
| Enterprise/Revenue | 4.56 |
| Enterprise/EBITDA | 17.54 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | 0.11 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.02 |
Income Statement
| Revenue | 1.34B |
| Revenue/Share | 11.37 |
| Gross Profit | 319.47M |
| EBITDA | 408.21M |
| Net Income | 107.37M |
| Diluted EPS | 0.9 |
Balance Sheet
| Total Cash | 52.96M |
| Total Cash/Share | 0.44 |
| Total Debt | 1.09B |
| Total Debt/Equity | 0.2 |
| Current Ratio | 1.05 |
| Book Value Per Share | 45.27 |
Price History
| 52-Week Change | -31.1 |
| 52-Week High | 67.3 |
| 52-Week Low | 39.6 |
| Moving Average 50 Days | 44.49 |
| Moving Average 200 Days | 51.09 |
Statistics
| Average Volume | 239,281 |
| Shares Outstanding | 119.51M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.5 |
| Trailing Annual Dividend Yield | 3.47 |
| Payout Ratio | 1.87 |
| Last Split Factor | 203:200 |
| Last Split Date | October 13, 2023 |
AD
